Stock Price Quote

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE728.60-3.1 (-0.42 %)
PREV CLOSE ( ) 731.70
OPEN PRICE ( ) 739.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 254886
TODAY'S LOW / HIGH ( )724.75 739.60
52 WK LOW / HIGH ( )356.75 739.6
NSE728.65-2.45 (-0.34 %)
PREV CLOSE( ) 731.10
OPEN PRICE ( ) 738.00
BID PRICE (QTY) 728.65 (23003)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6159882
TODAY'S LOW / HIGH( ) 724.50 739.65
52 WK LOW / HIGH ( )355.3 739.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000 / 022-24826951

Email cosecretary@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg, MCX

NEWS

08Aug Cipla submits newspaper publication
Cipla has submitted newspaper publication.The above information is a par..
27Jul Cipla, Precision Camshafts and Jenburk
Cipla has been granted regulatory approval by the Drug Controller Genera..
27Jul Cipla gains on getting DCGI’s nod to l
Cipla is currently trading at Rs. 669.10, up by 3.60 points or 0.54% fro..
25Jul Cipla gets DCGI’s nod to launch Ciplen
Cipla has been granted regulatory approval by the Drug Controller Genera..
24Jul Cipla all set to launch Favipiravir
Cipla is all set to launch Favipiravir, developed by the Council of Scie..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit610323181.7
Gross Profit 8324.6 29643.1
Operating Profit 990436001.4
Net Sales 31280.2126591.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4667.60 (6.04%)
M.Cap ( in Cr)7747.93
Valiant Organics (BSE)
peergroup  2610.70 (9.39%)
M.Cap ( in Cr)3171.80
Aarti Drugs (BSE)
peergroup  2353.60 (5.68%)
M.Cap ( in Cr)5483.89
Alkem Laboratories (BSE)
peergroup  2980.30 (4.06%)
M.Cap ( in Cr)35633.96
Abbott India (BSE)
peergroup  16188.60 (0.29%)
M.Cap ( in Cr)34399.65

Shareholding Pattern

FI/BANKS/INSURANCE 4.78%
PROMOTERS 36.68%
NON-INSTITUTION 23.4%
MUTUAL FUNDS/UTI 16.29%
FII 0.01%
GOVERNMENT 0%

About Cipla Ltd.

Cipla Ltd. was incorporated in the year 1935. Its today's share price is 728.6. Its current market capitalisation stands at Rs 58747.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 271312.3 Cr and Total Income of Rs.175013.7 Cr. The company's management includes Samina Hamied, Punita Lal, Peter Mugyenyi, Naina Lal Kidwai, Ashok Sinha, Adil Zainulbhai, S Radhakrishnan, Umang Vohra, MK Hamied, Y K Hamied.

It is listed on the BSE with a BSE Code of 500087 , NSE with an NSE Symbol of CIPLA and ISIN of INE059A01026. It's Registered office is at Cipla House,Peninsula Business Park,Ganpatrao Kadam Marg, Lower ParelMumbai-400013, Maharashtra. Their Registrars are ACC Ltd. It's auditors are RGN Price & Co, RS Bharucha & Co, V Sankar Aiyar & Co, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)